WA
SGEN

Winfield Associates’s Seagen Inc. Common Stock SGEN Stock Holding History

Winfield Associates’s Portfolio SGEN Stock Details SGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-40
Closed -$3K – 700
2017
Q4 		$3K Hold
40
– – ﹤0.01% 621
2017
Q3 		$2K Hold
40
– – ﹤0.01% 636
2017
Q2 		$2K Hold
40
– – ﹤0.01% 721
2017
Q1 		$3K Hold
40
– – ﹤0.01% 557
2016
Q4 		$2K Hold
40
– – ﹤0.01% 577
2016
Q3 		$2K Hold
40
– – ﹤0.01% 564
2016
Q2 		$2K Buy
+40
New +$1.52K ﹤0.01% 555

Other funds holding SGEN

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Winfield Associates's SGEN Position: Q1 2018 in Review

Winfield Associates sold out of Seagen Inc. Common Stock (SGEN) in Q1 2018, closing a stake of 40 shares — an estimated $3K sold.

Winfield Associates first reported a position in SGEN in Q2 2016 and held it in 7 quarters. The position peaked at $3K in Q4 2017. 287 funds tracked by Wall St. Rank hold SGEN as of Q1 2018.

  • Winfield Associates reported no remaining Seagen Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Winfield Associates sold 40 Seagen Inc. Common Stock shares in Q1 2018, an estimated $3K.
  • Winfield Associates first reported a position in Seagen Inc. Common Stock in Q2 2016 and held it in 7 quarters.
  • Winfield Associates's Seagen Inc. Common Stock position peaked at $3K in Q4 2017.
  • 287 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q1 2018.

Based on Winfield Associates's 13F filing for Q1 2018, filed 10 May 2018.